Silvercrest Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.6M Buy
290,559
+205,452
+241% +$25.2M 0.26% 97
2026
Q1
$10M Buy
85,107
+81,982
+2,623% +$11.5M 0.07% 303
2025
Q4
$512K Buy
+3,125
New +$489K ﹤0.01% 712
2024
Q2
Sell
-6,872
Closed -$1.26M 936
2024
Q1
$1.26M Buy
6,872
+851
+14% +$162K 0.01% 577
2023
Q4
$1.08M Buy
6,021
+432
+8% +$67.2K 0.01% 581
2023
Q3
$889K Buy
5,589
+505
+10% +$82.6K 0.01% 617
2023
Q2
$719K Buy
+5,084
New +$815K 0.01% 633

Other funds holding RGEN

Silvercrest Asset Management's RGEN Position: Q2 2026 in Review

Silvercrest Asset Management increased its Repligen (RGEN) stake by 241% in Q2 2026, buying an estimated $25.2M and bringing the position to 290,559 shares worth $39.6M. The position accounts for 0.26% of the portfolio, ranked #97.

Silvercrest Asset Management first reported a position in RGEN in Q2 2023 and has held it in 7 quarters since. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Silvercrest Asset Management held 290,559 shares of Repligen worth $39.6M as of Q2 2026.
  • Silvercrest Asset Management bought 205,452 Repligen shares in Q2 2026, an estimated $25.2M.
  • Repligen made up 0.26% of Silvercrest Asset Management's portfolio in Q2 2026, its #97 holding.
  • Silvercrest Asset Management first reported a position in Repligen in Q2 2023 and has held it in 7 quarters since.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.